TARDBP and Cognitive impairment: Interestingly, some reports have also identified C9orf72 patients with ALS and FTD presenting with cognitive impairment but with minimally TDP-43 inclusions underscoring the influence of other physiopathological mechanisms such as dipeptide repeat accumulation and RNA foci in the appearance of cognitive impairment (63, 108).